Biodesix Inc (BDSX) stock
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$8.88−0.12 (-1.33%)
Close on Nov 17, 2026Market cap $93.69MP/E –Yield –
Biodesix operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Biodesix's operating income for the twelve months ending Jun 30, 2026 was -$20.61M. For fiscal 2025 it was -$27.87M. The highest annual figure on record is -$22.93M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$27.87M | – |
| FY2024 | Dec 31, 2024 | -$34.50M | – |
| FY2023 | Dec 31, 2023 | -$41.34M | – |
| FY2022 | Dec 31, 2022 | -$50.59M | – |
| FY2021 | Dec 31, 2021 | -$40.94M | – |
| FY2020 | Dec 31, 2020 | -$22.93M | – |
| FY2019 | Dec 31, 2019 | -$26.74M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.39M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.97M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.05M | – |
| Q2 FY2025 | Jun 30, 2025 | -$9.72M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.14M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.65M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.59M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.24M | – |
| Q1 FY2024 | Mar 31, 2024 | -$11.02M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.87M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.17M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.93M | – |
| Q1 FY2023 | Mar 31, 2023 | -$16.37M | – |
| Q4 FY2022 | Dec 31, 2022 | -$13.89M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.61M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.63M | – |
| Q1 FY2022 | Mar 31, 2022 | -$14.46M | – |
| Q4 FY2021 | Dec 31, 2021 | -$11.68M | – |
| Q3 FY2021 | Sep 30, 2021 | -$13.09M | – |
| Q2 FY2021 | Jun 30, 2021 | -$10.59M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.58M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.65M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.24M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.62M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.42M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.54M | – |
| Q3 FY2019 | Sep 30, 2019 | -$9.03M | – |
See a number that looks wrong?